Skip to main content
VCbacked
Log inGet Started

Parse Biosciences

Seattle, United States

Parse Biosciences is a biotechnology startup company that develops single-cell sequencing kit solutions for researchers.

$50.0M raised
Dec 2023
Series C
BioinformaticsBiotechnologyGeneticsLife Science

Top Investors

National Science FoundationSoleus CapitalHorizon Technology FinanceJanus Henderson InvestorsMarshall Wace

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Parse Biosciences

How much funding has Parse Biosciences raised?
Parse Biosciences has raised $50.0M in total funding. The most recent round was Series C. The last funding was announced in December 2023.
Who are Parse Biosciences's investors?
Parse Biosciences's investors include National Science Foundation, Soleus Capital, Horizon Technology Finance, Janus Henderson Investors, Marshall Wace.
Where is Parse Biosciences headquartered?
Parse Biosciences is headquartered in Seattle, United States.
What does Parse Biosciences do?
Parse Biosciences is a biotechnology startup company that develops single-cell sequencing kit solutions for researchers.
What stage is Parse Biosciences at?
Parse Biosciences is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Parse Biosciences — Funding & Investors." VCBacked, December 14, 2023, https://www.vcbacked.co/company/parse-biosciences. Accessed June 17, 2026.
APA
VCBacked. (2023). Parse Biosciences — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/parse-biosciences
Wikipedia (cite web)
{{cite web |title=Parse Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/parse-biosciences |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Bioinformatics

View all
CellPly
Bologna$3.6M
10x Science
San Francisco
Cell Type
San Francisco
metaBIX Biotech
Montevideo$1.3M
Biotasmart
Valencia$591K
LigronBio
Newark